Campylobacter jejuni (Jones et al.) Veron and Chatelain
商品貨號
B204584
Deposited As
Campylobacter coli (Doyle) Veron and Chatelain
Strain Designations
MK219
Isolation
Human feces, Canada
Biosafety Level
2
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Antigenic Properties
Serotype O:30
RefPenner JL, et al. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2: 378-383, 1983. PubMed: 6628376
Product Format
freeze-dried
Preceptrol®
no
Type Strain
no
Medium
ATCC® Medium 260: Trypticase soy agar/broth with defibrinated sheep blood
Growth Conditions
Temperature: 37°C
Atmosphere: Microaerophilic
Name of Depositor
JL Penner
Chain of Custody
ATCC <<--JL Penner<<--M. Karmali
References
Penner JL, et al. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2: 378-383, 1983. PubMed: 6628376
Penner JL, et al. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2: 378-383, 1983. PubMed: 6628376
Penner JL, et al. Serotyping of Campylobacter jejuni and Campylobacter coli on the basis of thermostable antigens. Eur. J. Clin. Microbiol. 2: 378-383, 1983. PubMed: 6628376
Cross References
Nucleotide (GenBank) :
AX111102
Sequence 1835 from Patent WO0123604.
Nucleotide (GenBank) :
AX111116
Sequence 1849 from Patent WO0123604.
Nucleotide (GenBank) :
AX111451
Sequence 2184 from Patent WO0123604.